Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI +/- Bevacizumab vs Irinotecan +/- Bevacizumab in Second-line Metastatic Colorectal Cancer
NCT03303495Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2011
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil, folinic acid in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Started Nov 2011; status: recruiting.
02
Drugs
fluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03303495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03303495.